Showing results (1151-1160 of 1,190) with videos related to

Sort By:
Pageof 119
Journal of Travel Medicine|July 15, 2020
Detection of SARS-CoV-2 RNA in commercial passenger aircraft and cruise ship wastewater: a surveillance tool for assessing the presence of COVID-19 infected travellersWarish Ahmed, Paul M Bertsch, Nicola Angel, et al.
The New England Journal of Medicine|March 17, 1983
Cerebral arterial spasm--a controlled trial of nimodipine in patients with subarachnoid hemorrhageG S Allen, H S Ahn, T J Preziosi, et al.
Blood|December 14, 2011
Administration of bortezomib before and after autologous stem cell transplantation improves outcome in multiple myeloma patients with deletion 17pKai Neben, Henk M Lokhorst, Anna Jauch, et al.
Leukemia|July 21, 2020
Bortezomib-based induction, high-dose melphalan and lenalidomide maintenance in myeloma up to 70 years of ageElias K Mai, Kaya Miah, Uta Bertsch, et al.
Cell Reports. Medicine|November 9, 2020
Pharmacological Inhibition of Acid Sphingomyelinase Prevents Uptake of SARS-CoV-2 by Epithelial CellsAlexander Carpinteiro, Michael J Edwards, Markus Hoffmann, et al.
Cerebrovascular Diseases (Basel, Switzerland)|August 27, 2020
Mobile Stroke Unit in the UK Healthcare System: Avoidance of Unnecessary Accident and Emergency AdmissionsIris Q Grunwald, Daniel J Phillips, David Sexby, et al.
The Science of the Total Environment|January 20, 2022
Detection of the Omicron (B.1.1.529) variant of SARS-CoV-2 in aircraft wastewaterWarish Ahmed, Aaron Bivins, Wendy J M Smith, et al.
Neurological Research and Practice|June 1, 2021
Effects of state-wide implementation of the Los Angeles Motor Scale for triage of stroke patients in clinical practiceStefanie Behnke, Thomas Schlechtriemen, Andreas Binder, et al.
Gastroenterology|October 15, 2013
Nuclear death receptor TRAIL-R2 inhibits maturation of let-7 and promotes proliferation of pancreatic and other tumor cellsVerena Haselmann, Alexandra Kurz, Uwe Bertsch, et al.
Leukemia|February 9, 2020
Response-adapted lenalidomide maintenance in newly diagnosed myeloma: results from the phase III GMMG-MM5 trialHartmut Goldschmidt, Elias K Mai, Jan Dürig, et al.
Pageof 119